U.S. Protein Expression Market – Analysis and Forecast (2019–2024)

1. U.S. Protein Expression Market

2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

3. U.S. Protein Expression Market The U.S. protein expression market is expected to grow at a CAGR of 11.6% during the forecast period with its market size predicted to reach USD 1.2 billion by 2024. The U.S. protein expression market is primarily driven by the factors such as the increasing prevalence of chronic diseases, increasing investment for recombinant protein expression, advancement in technology for expression systems, increasing geriatric population, and robust growth of the life sciences industry in the country. Prokaryotic expression systems and mammalian cell expression systems are the major contributors to the protein expression industry in the region.

4. U.S. Protein Expression Market The increasing prevalence of chronic diseases, increasing funding for recombinant protein expression from government and non-government organizations, advancement in technology for expression systems, increasing geriatric population, and robust growth of the life sciences industry in the country are the primary growth drivers for the U.S. protein expression industry. Different government and non-government organizations are funding investment for the development of protein biologics. Technological advancements such as microfluidics have advanced the approach of protein expression system such as a cell-free expression system. Cell-free expression systems provide a very high yield of proteins are being proved efficient for the development of protein biologics.

5. U.S. Protein Expression Market The high cost of reagents and equipment, complexities associated with purification of proteins are the key challenges faced by the U.S. protein expression industry. Some of the key players operating in the U.S. protein expression market are New England Biolabs, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Takara Bio Inc., Lonza Group Ltd., Merck KGaA, Promega Corporation, Genscript Biotech Corporation, Agilent Technologies Inc., and Bio-Rad Laboratories, Inc.

6. For Sample Report :- https://www.vynzresearch.com/healthcare/us-protein-expression-market/request-sample www.vynzresearch.com